A. H. . Kumar and M. George, “Evaluating the Chrono-pharmacology of Icosapent Ethyl to Assess its Therapeutic Efficacy in Reducing Hypertriglyceridemia Associated Cardiovascular Events”, BEMS Reports, vol. 5, no. 2, pp. 26–28, Feb. 2021.